Skip to main content
Premium Trial:

Request an Annual Quote

OGT, Agilent Partner on Microarray Development

NEW YORK (GenomeWeb News) - Oxford Gene Technology said today that it has inked a collaborative agreement with Agilent Technologies that gives it access to Agilent’s microarray platform and makes Agilent an OEM supplier of OGT-designed microarrays.
 
Under the deal, OGT becomes an Agilent certified service provider and the companies plan to create a “Center of Microarray Excellence” that will focus on emerging microarray applications, such as array-CGH, ChIP-onchip, methylation, and microRNA analysis.   
 
OGT said it will use Agilent’s 2100 Bioanalyzer platform and GeneSpring microarray analysis software in the center.
 
The agreement follows a number of licensing agreements that OGT has recently signed with MassTag Technologies, NimbleGen, and Illumina.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.